Home >> Marketplace Directory >> Advanced Cell Diagnostics awarded NCI grant, 12/14

Advanced Cell Diagnostics awarded NCI grant, 12/14

image_pdfCreate PDF
RNAscope Ig kappa (black) and lambda (red) mRNA in lambda-restricted B-cell lymphoma

RNAscope Ig kappa (black) and lambda (red) mRNA in lambda-restricted B-cell lymphoma

December 2014—Advanced Cell Diagnostics has been awarded a two-year, $1.4 million grant from the National Cancer Institute under its Small Business Innovation Research Grant phase two program. ACD and its academic partner, Cleveland Clinic, will use the grant to develop and validate a diagnostic test based on ACD’s proprietary RNAscope technology for discriminating various B-cell non-Hodgkin lymphomas from benign lymphoproliferative diseases.

“This is an important advance in our ability to accurately diagnose B-cell lymphomas because conventional IHC and CISH methods to establish clonality simply don’t work for the majority of NHLs for various reasons,” James Cook, MD, PhD, hematopathologist and co-investigator at Cleveland Clinic, said in a statement.

Advanced Cell Diagnostics, 510-259-9802

CAP TODAY
X